SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

Vertex Pharmaceuticals earnings below expectations at 4.76 USD

Vertex Pharmaceuticals (VRTX) released earnings per share at 4.76 USD, compared to market expectations of 4.88 USD.

SquawkNews Desk

Vertex Pharmaceuticals (VRTX) released earnings per share at 4.76 USD, compared to market expectations of 4.88 USD.

Related stories

UMH Properties Expects 2026 Normalized FFO of $0.99-$1.03 UMH Properties expects full-year 2026 normalized FFO of $0.99-$1.03, versus a FactSet estimate of $1. M impact | EARNINGS | Nov 02, 2026, 10:34 PM UTC Innovative Industrial Properties Posts Q3 Adjusted FFO of $1.96 Q3 adjusted FFO was $1.96, versus the FactSet estimate of $1.71. M impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC 5N Plus On Track to Reach High End of 2026 EBITDA Guidance 5N Plus said it is on track to achieve the high end of its full-year 2026 adjusted EBITDA guidance range. L impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC UMH Properties Reports Q3 Normalized FFO of $0.26 UMH Properties reported Q3 normalized FFO of $0.26, matching the FactSet estimate of $0.26. M impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC Toromont Reports Q3 Basic EPS of CAD 2.35 L impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC RioCan Q3 Core FFO per Unit Rises 5.1% RioCan said third-quarter core FFO per unit rose 5.1%, citing retail occupancy strength. M impact | EARNINGS | Nov 02, 2026, 10:32 PM UTC